Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Biopharmaceutical Statistics is Scopus-indexed (Q2, CiteScore 2.7), ABDC C, WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Taylor & Francis Online.
Checked against the index lists dated .
ISSN 1054-3406Verify ISSN ↗1520-5711Verify ISSN ↗
Publisher: Taylor & Francis Online
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Statistics and Probability | 122 / 303 | 59th | Q2 |
| Pharmacology (medical) | 168 / 278 | 39th | Q3 |
| Pharmacology | 224 / 328 | 31st | Q3 |
Not listed in: DOAJ, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1991–present, best quartile Q2, CiteScore 2.7.
Journal of Biopharmaceutical Statistics is Q2 in Statistics and Probability (rank 122 of 303), Q3 in Pharmacology (medical) (rank 168 of 278) and Q3 in Pharmacology (rank 224 of 328), by CiteScore 2025.
Journal of Biopharmaceutical Statistics is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.7, which places it in quartile Q2 at the 59th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.680, quartile Q2, with an H-index of 60.
Journal of Biopharmaceutical Statistics is published by Taylor & Francis Online. Its print ISSN is 1054-3406 and its online ISSN is 1520-5711.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
It is rated C in the ABDC Journal Quality List 2025 under Statistics.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Journal of Biopharmaceutical Statistics has an h-index of 73 and a 2-year mean of 0.97 citations per paper (OpenAlex). Its Scopus CiteScore is 2.7, quartile Q2. On 2-year citations it ranks #161 of 294 Scopus journals in Statistics and Probability.
Journal of Biopharmaceutical Statistics published 93 papers in 2025; its busiest recent year was 2017 with 105. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 91 research articles (2025–2026), authors are most often from United States (53.1%), Japan (6.6%) and Germany (6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.8 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.